CVC Capital Partners (CVC) is a global private markets investment firm founded in 1981. The firm advises funds focused on private equity, secondaries, and credit, investing across Europe, the Americas, and Asia. CVC structures include buyouts, minority investments, and corporate carve‑outs, with a network of offices supporting deal sourcing and portfolio management across multiple regions.
For the chemical industry, CVC is active across the broader industrial and materials value chain, including specialty and performance chemicals, distribution, packaging, and industrial services. Its transactions frequently involve mid‑ to large‑cap businesses and complex carve‑outs from diversified groups. CVC’s investment approach typically emphasizes operational improvement, strategic repositioning, and consolidation through buy‑and‑build strategies, making it a regular participant in M&A processes involving chemical producers and adjacent sectors.
Also known as CVC.
Food Ingredients business sold for ~$4.3B (≈10x EBITDA); seller retains ~10% stake; net proceeds ~$3.8B for debt reduction, buybacks and reinvestment; close by end Q2 2027.
Planned CEO handover on July 1, 2026; outgoing CEO to retire; European COO departs June 30; CMO to become COO Europe; focus on continuity and family ownership.
The company aims to enhance growth, EBITDA margins, and cash flow, with a share repurchase program and strategic updates amid ongoing macroeconomic challenges.
Financials reclassified post-ANH divestment; new reporting structure and KPI adjustments outlined; further details to follow in 2026.
The divestment is valued at €2.2 billion, with dsm-firmenich retaining a 20% stake. The deal includes a share buyback and a stable dividend policy. Completion expected by end of 2026.
Helmut Kaschenz to step down as CFO in 2026 after key achievements in finance and strategy. Successor not yet named.
